HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Amicosante, M. Articles by Saltini, C. Search for Related Content PubMed PubMed Citation Articles by Amicosante, M. Articles by Saltini, C.

HLA-DP-unrestricted TNF- release in beryllium-stimulated peripheral blood mononuclear cells

¹ Laboratory of Clinical Pathology, and ² Division of Respiratory Diseases of the University of "Tor Vergata", National Institute for Infectious Diseases (L. Spallanzani, IRCCS), Rome, ³ Division of Occupational Medicine, Policlinico, Modena, and ⁴ Division of Pulmonary Medicine, Policlinico, Modena, Italy. ⁵ Pulmonary and Intensive Care Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA

CORRESPONDENCE: M. Amicosante, Laboratory of Clinical Pathology, INMI L. Spallanzani-IRCCS, Via Portuense 292, I-00149, Rome, Italy. Fax: 39 065582237. E-mail: amicosante@inmi.it

Keywords: berylliosis, cytokines, human leukocyte antigen-DPGlu69, interferon-, T-cell proliferation, tumour necrosis factor-

Received: November 16, 2001
Accepted June 12, 2002

This study was supported by grants from US Dept of Energy (DoE) grant DE-FG02-93ER61714 and grant 99060855594 from MIUR, Italy.

Berylliosis is a granulomatous disorder of the lung caused by inhalation of beryllium (Be) and dominated by the accumulation of CD4+ T-helper (Th)1 memory T-cells proliferating in response to Be in the lower respiratory tract. Two gene markers have been associated with susceptibility to berylliosis: 1) the human leucocyte antigen (HLA)-DP gene whose allelic variants, carrying glutamate in position 69 of the ß-chain (HLA-DPGlu69), can bind Be directly and present it to interferon (IFN)- releasing Th1 T-cell clones from patients with berylliosis; and 2) the cytokine gene tumour necrosis factor (TNF)- which has been shown to increase berylliosis risk independent of HLA-DPGlu69.

In order to determine whether TNF- release was triggered by Th1 T-cell activation by Be stimulation in the context of HLA-DPGlu69 molecules, the proliferation of BeSO₄-stimulated blood mononuclear cells and the release of IFN-, TNF-, RANTES (regulated on activation normal T-cell expressed and secreted), granulocyte-macrophage colony-stimulating factor, interleukin (IL)-4, IL-6, IL-8, IL-10 and IL-12 by BeSO₄-stimulated blood mononuclear cells was quantified in 11 individuals with berylliosis using an anti-HLA-DP antibody as a probe for HLA-DP restricted T-cell activation.

While proliferation and IFN- release were completely abrogated by HLA-DP inhibition (inhibition with anti-HLA-DP monoclonal antibody (mAb): 88±16 and 77±16%, respectively; anti-HLA-DR: 29±38 and 14±10%, respectively), the release of TNF- was not (inhibition with anti-HLA-DP mAb: 8.9±7.8%). No other cytokine was detected at significant levels. Moreover, Be was able to induce TNF- production in healthy control subjects not exposed to Be in the absence of T-cell proliferation and IFN- production.

In conclusion, these data suggest that the tumour necrosis factor- response of mononuclear cells is independent of the activation of beryllium-specific human leucocyte anitgen-DP restricted T-cells, which is consistent with the finding that the tumour necrosis factorA2 and the human leucocyte anitgen-DPGlu69 genetic markers are independently interacting in increasing berylliosis risk.

This article has been cited by other articles:

				R. T. Sawyer, A. P. Fontenot, T. A. Barnes, C. E. Parsons, B. C. Tooker, L. A. Maier, M. M. Gillespie, E. B. Gottschall, L. Silveira, J. Hagman, et al. Beryllium-Induced TNF-{alpha} Production Is Transcription-Dependent in Chronic Beryllium Disease Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 191 - 200. [Abstract] [Full Text] [PDF]

				J. Muller-Quernheim, K. I. Gaede, E. Fireman, and G. Zissel Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients Eur. Respir. J., June 1, 2006; 27(6): 1190 - 1195. [Abstract] [Full Text] [PDF]

				R. T. Sawyer, C. E. Parsons, A. P. Fontenot, L. A. Maier, M. M. Gillespie, E. B. Gottschall, L. Silveira, and L. S. Newman Beryllium-Induced Tumor Necrosis Factor-{alpha} Production by CD4+ T Cells Is Mediated by HLA-DP Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 122 - 130. [Abstract] [Full Text] [PDF]

				B. P. Barna, D. A. Culver, B. Yen-Lieberman, R. A. Dweik, and M. J. Thomassen Clinical Application of Beryllium Lymphocyte Proliferation Testing Clin. Vaccine Immunol., November 1, 2003; 10(6): 990 - 994. [Full Text] [PDF]